{
    "2018-01-16": [
        [
            {
                "time": "2018-01-15",
                "original_text": "四大因素驱动医药股行情 千亿元级市值股有望扩容",
                "features": {
                    "keywords": [
                        "医药股",
                        "行情",
                        "千亿元级市值",
                        "扩容"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "【医药】江琦、池陈森：2018年医药生物投资策略：拥抱创新，紧抓龙头",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "创新",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}